FULL YEAR TRADING AND OPERATIONAL UPDATE

Paris, France and Camberley, UK – 28 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited revenues for the year ended 31 December 2019 and provides an operational update. The Company will report its full year results in April 2020. http://novacyt.com/wp-content/uploads/2020/01/Novacyt-full-year-trading-and-operational-update-ENGLISH.pdf

Visit Page

Liquidity Agreement Monthly Update and Total Voting Rights

Paris, France and Camberley, UK – 2 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised

Visit Page

Completion of NOVAprep® business sale

Paris, France and Camberley, UK – 27 December 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has completed the sale of NOVAprep® assets to Algimed Trade Ltd. (“Algimed”), for a total consideration of €400,000 and a 10% royalty on sales in certain defined territories. Algimed specialises in

Visit Page